Cochlear Receives “Underperform” Rating from Credit Suisse (COH)
Cochlear (ASX:COH)‘s stock had its “underperform” rating reiterated by Credit Suisse in a research note issued on Thursday, AR Network reports.
A number of other analysts have also recently weighed in on COH. Analysts at Bank of America Corp. reiterated an “underperform” rating on shares of Cochlear in a research note to investors on Wednesday. Four analysts have rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. Cochlear presently has an average rating of “Hold” and a consensus target price of A$70.54 ($66.55).
Cochlear (ASX:COH) traded up 1.60% on Thursday, hitting A$60.930. 117,237 shares of the company’s stock traded hands. Cochlear has a one year low of A$52.710 and a one year high of A$82.870. The stock has a 50-day moving average of A$58.85 and a 200-day moving average of A$63.13. The company has a market cap of A$3.468 billion and a P/E ratio of 25.80.
Cochlear Limited (ASX:COH) is an Australia-based company, which operates in the implantable hearing device industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.